Formats for Recording and Reporting. Annexure XV

Similar documents
Guidelines for Performance based Payment for ASHA under National Leprosy Eradication Programme

HOW TO MONITOR LEPROSY ELIMINATION IN YOUR WORKING AREA. World Health Organization

Rajbir Singh German Leprosy and TB Relief Association

Regional Strategy for Sustaining Leprosy Services and Further Reducing the Burden of Leprosy

Management information system for leprosy eradication programme---an alternative information system *

NGO Schemes in National Leprosy Eradication Programme (NLEP)-2013

APPLICATION PACK BURJ DAYCARE NURSERY

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

- Primary 1,208 - Junior High School High School Intermediate Graduate 14 - Post Graduate 03 No. of Urban Slums 227

Educational Posters and Leaflets on Leprosy: Raising Awareness of Leprosy for Health-Care Workers in Rural South Africa

Community Health Services in Bristol Community Learning Disabilities Team

Cobimetinib (Cotellic ) ( koe-bi-me-ti-nib )

Table 1. State-Wise Area, Districts and Villages in India 14. State-Wise Rural and Urban Population as per 1991 and 2001 Census

Part 1. Rural Health Care System in India 1. Table 1. State-Wise Area, Districts and Villages in India 28

Procedure For Taking Walk In Patients

ARE WE MISSING RELAPSES IN LEPROSY?

One year follow up of acohort of suspected leprosy cases: findings from a Leprosy Selective Special Drive in Gadchiroli District, Maharashtra, India

Patient satisfaction in national leprosy eradication programme Mohite RV 1, Mohite VR 2, Durgawale PM 3

Sentinel node biopsy. Patient Information to be retained by patient

North West Residential Support Services Inc. Policies & Procedures PROCEDURES FOR THE ADMINISTRATION OF MEDICATION IN SHARED HOMES

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

Application of eye drops

PRE-ASSESSMENT GUIDELINES AND FORMS FOR PHC/CHC

MULTI-AGENCY REFERRAL FORM

PREPARATION AND ADMINISTRATION

Expiry Date: January 2009 Template Version: Page 1 of 7

Hector Naidoo and Associates Future Leaders Bursary BURSARY APPLICATION FORM

WORKPLACE HEALTH AND SAFETY & FIRST AID POLICY

Programme Implementation Plan (PIP) for 12 th Plan Period ( to )

Managing medicines in care homes

Incident, Accident and Near Miss Procedure

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

University of Miami Clinical Enterprise Technologies

WHO/HTM/TB/ Task analysis. The basis for development of training in management of tuberculosis

Last Name First Middle. Mailing Address. City State Zip Phone. Date of Birth Age Soc. Sec# Cell. Employer Work Phone

Medicines Reconciliation Standard Operating Procedures

Persons Affected with Leprosy Homes 4 No. of PAL living in these homes 135

MEDICINES RECONCILIATION GUIDELINE Document Reference

Country experience on engaging large hospitals - INDIA

Federal Ministry of Health

Madurai Health and Leprosy Relief Centre

Etoposide (VePesid ) ( e-toe-poe-side )

Facilitative Counselling for better patient management in leprosy

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

Paragon Infusion Centers Patient Information

PATIENT INFORMATION. Address: Sex: City: State: address: Cell Phone: Home Phone: Work Phone: address: Cell Phone:

Patient Identifiers: Facial Recognition Patient Address DOB (month/day year) / / UHHC. Month Day Year / / Month Day Year

Manchester Royal Eye Hospital. Welcome to the Acute Ophthalmic Services at Manchester Royal Eye Hospital

I. PROFORMA FOR PROGRESS REPORT

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Medicine Management Policy

CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES

Document Details. Patient Group Direction

interrai New Zealand National Standards

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING

NURSING HOMES OPERATION REGULATION

Leprosy Elimination Monitoring in India

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

MEDICINES CONTROL COUNCIL

W e l c o m e t o B i l l e r i c a C h i r o p r a c t i c

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

St John the Evangelist RCP School

HOW PROCESS MEASURES ARE CALCULATED

New Patient Registration Form NJR_NP_F100

PHYSICIAN S RECOMMENDATION FOR PEDIATRIC CARE INSTRUCTIONS FOR COMPLETING THE PEDIATRIC CARE FORM DMA-6(A)

Persons affected by leprosy homes No. of persons affected by leprosy living in these homes Not Applicable

Persons Affected with Leprosy Homes No. of PAL living in these homes

THE BOARD OF THE EURASIAN ECONOMIC COMMISSION RESOLUTION. dated December 22, 2015 N 174

Hostel for SC/ST Students- HFS

NSS Units under Gauhati University NSS Cell are requested to send nominations for Awards for the categories mentioned below:

SWEET HOME SCHOOL DISTRICT FAMILY AND MEDICAL LEAVE HANDBOOK

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Colorectal Surgery Enhanced Recovery Programme Preoperative Information Useful information Care

PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT

Patient Group Direction For the supply of Fusidic Acid 2% Cream

Language, Literacy and Numeracy Core Skills Survey - (Community Services)

Government of Andhra Pradesh Commissioner of Health & Family Welfare Recruitment Notification

User manual for Renewal Validity

Supporting Children at School with Medical Conditions

First Aid and Medicines Procedure

PROFORMA FOR SUBMISSION OF PROJECTS UNDER BIOTECHNOLOGY- BASED PROGRAMMES FOR RURAL DEVELOPMENT

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment

SOFTWARE USER GUIDE PRIMARYCLINIC PRACTICE (PRACNET) Commercial-in-Confidence

Standard Operating Procedure for When required (PRN) medicines in care homes

Recognizing and Reporting Acute Change of Condition

Standard operating procedures for the conduct of outreach training and supportive supervision

SRIMATHI SUNDARAVALLI MEMORIAL RESIDENCY CHENNAI SUBHASHRAYA - AN IDEAL HOME FOR SENIOR CITIZENS Application Form for Admission

Transnational Skill Standards Pharmacy Assistant

2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012)

12/17/2015 F 0000 F 0314 F 0314 SS=G PRINTED: 9/12/2016 DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH CARE FINANCING ADMINISTRATION SQC111

Dow University of Health Sciences Karachi Department of Postgraduate Studies Baba-e-Urdu Road Karachi PAKISTAN

PATIENT GROUP DIRECTION (PGD) FOR

Please read the following carefully before completing this application

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

MINNESOTA. Downloaded January 2011

Inspection Protocol Skin and Wound Care. Definition / Description. Use. Resident-related Triggered

Certification of Health Care Provider for Medical Leave (Family and Medical Leave Act of 1993 and all related state leave laws)

Medical Needs Policy. Policy Date: March 2017

MONITORING AND EVALUATION PLAN

Transcription:

Formats for Recording and Reporting Annexure XV

1.0 Guidelines to fill up the Patient Card This card will be maintained at sub centre, where the PMW will enter dates of subsequent monthly doses collection by patient, till the last dose required and then discharge the patient on the due date of discharge and record accordingly. After every monthly doses supplied and achieving end status, the MPW will also ensure updating the Treatment Register at the PHC, on their next visit for any purpose Cell Information to be filled Registration No Running number for the fiscal year at PHC level starts as 001 on first day of the month of April Name Full name Address Full postal address and identification marks near the house to facilitate tracing of defaulter Duration of To be ascertained from case history to be written in months Disease Age In number of completed years PB & MB PB 1 to 5 patches and/or 1 nerve affected MB 6 and more patches and/or 2 more nerve affected Visible deformity Write Gr 1, for grade one disability, if there is only loss of sensation and Gr 2 for visible deformity New Case (Tick) A new case is defined as person with signs of leprosy who have never received treatment before Other Type Under NLEP all previously treated cases needing further treatment are recorded as other cases. It has been decided that all migrant cases from another state reporting at any state. Health Institution will also be grouped under this category. Specify the category like re-entry, transferred in, referred, change in classification or relapse. Date of first dose Write date as day/ month/ year of giving first blister pack of MDT, client swallows medicine in the presence of health worker/ pharmacist Date of Write date of collection of the subsequent dose as it will help in following the subsequent doses person who has not come to collect medicine. Do not tick. In case person has taken accompanied MDT write the date in the first cell and connect that cell with the other cells (number of cells corresponding to the number of extra blister packs taken) by a line with arrow mark in the end. Date of discharge Write date of completion of last blister pack as day/ month/ year discharge Refer to End Status Back of the card Write date of referral, place of referral and reason for referral Tick/ write RFT Released from treatment if person with PB leprosy has taken 6 blister packs in 9 months and that with MB leprosy 12 blister packs in 18 months. Tick Others: if person has not completed the treatment and write defaulter, died, migrated or unknown depending on the status. You may write the details for reference in subsequent visits After achieving the End Status, the MPW should put her/his signature on the patient card and retain the same at sub centre for future reference. In urban situation also the same card is to be used. However appropriate Health unit, Area and Region may be indicated in the place of sub centre /PHC/Block lxxiv

L.F. 01 NATIONAL LEPROSY ERADICATION PROGRAMME (NELP) PATIENT CARD Sub centre PHC Block/CHC Districts State Registration Number: SC ST Others Name Age Female Male Address Duration of the disease Classification PB MB New Case Visible Deformity Yes No Remarks Date of First Dose AFTER ENTERING ABOVE INFORMATION IN THE PHC TREATMENT RECORD, THIS PATIENT CARD IS TO BE TRANSFERRED TO SUB CENTER FOR DELIVERY OF SUBSEQUENT DOSES Other Type (Specify) Signature of Medical Officer Date of subsequent doses: 2 3 4 5 6 PB (Final) Date of discharge 7 8 9 10 11 12 End Status RFT Others (specify) THIS CARD IS TO BE MAINTAINED AT SUB CENRE. AFTER EVERY DOSE, UPDATE THE PHC TREATMENT RECORD. AFTER ACHIEVING END STATUS, THEMPW SHOULD SIGN THISCARD AND RETAIN AT SUB Registration Number Classification CENTRE FOR FUTURE REFERENE Guidelines to fill-up this card Running number for the fiscal year at PHC level PB- 1 to 5 patches and/or 1 nerve affected MB 6 and more patches and/or 2 or more nerve affected Signature of Sub centre MPW New Case Other Type End Status A leprosy patient who has not taken MDT drugs anywhere earlier Includes Immigrant, Relapse, Referral or Restart of treatment RFT Released From Treatment OTHERS DEFAULTER (Case of PB or MB consecutively absent for a period of 12 months from the last dose)/died/migrated/unknown *In Urban situation, this same card I to be used. However, appropriate Health Unit, Area and Region may be Indicated in the place of Sub center/phc/block lxxv

Note: Categorization of other cases (recorded for PB and MB) (a) Relapse Relapse is defined as the re-occurrence of the disease at any time after the completion of a full course of treatment. Diagnosis must be evidence based and must be diagnosed after adequate screening. (b) Reentered for treatment - These are previously treated cases, where clinical assessment shows requirement of further treatment and patient admits that treatment was not completed. (c) Referred cases patient referred for completion of treatment (remaining doses) by tertiary or second level institutions after diagnosis and issue of first dose, or from another Health centre on patients request or migratory patient from another District/State. All referred cases should have a referral slip showing diagnosis and remaining doses to be given. (d) Change in classification persons with PB leprosy; reclassified to MB and need full course of MB treatment. (e) Cases from outside the state & Temporary migration or cross border cases. This information will be recorded in a separate register (LF-02/A) and reported separately in the monthly progress reports. Before deciding a case to be recorded as from other state, the residential status at the place of diagnosis be carefully examined. A person who is residing for more than six month and is likely to stay till completion of treatment, be recorded as indigenous case and will not be categorized under other cases. 2.0 Treatment Record The Treatment Record (L.F. 02) should be kept in a Register in all Primary Health Centers/Block PHC/CHC wherever leprosy cases are diagnosed and treated. As discussed earlier, at first the patient card is prepared by the Medical Officer diagnosing the case of leprosy. The information will thereafter be filled up in the Treatment Record. The Annual Serial Registration Number will also be available from this Register. The Medical Officer I/C of PHC/CHC etc. can give this responsibility to one of the General Health Care Staff working in the Health Centre. The information entered should be exactly similar to the one recorded in the patient card. The person(s) entrusted with responsibility of filling up the Treatment Record, should also ensure updating of the records of all patients being treated at sub centers on receipt of factual information from the concerned MPW(s). Any default on receipt of information should be promptly brought to the notice of the Medical Officer in-charge who will ensure updating of the record. The same L.F. 02 form is also to be used in all Hospitals, NGO institutions engaged in diagnosing and treating leprosy cases. The Name of PHC/Block PHC/CHC should be replaced by Name of Hospital/NGO Institution. The Registration Number will be changed every year starting from 001 on 1 st April of the Fiscal year (say 1 st April 2002 to 31 st March 2003). The treatment record will be retained in the Health Centre/Hospital/NGO institutions for future reference. lxxvi

LF - 02 NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP) PHC TREATMENT RECORD PHC Block PHC/ CHC DISTRICT Reg Sub No. Centre State Fiscal Year Name Address Age Sex SC/ PB/ M/F ST MB Date of Subsequent Doses New/ Others Visible Defor. Y/N Date of first dose 2 3 4 5 6 PB (final) 7 8 9 10 11 12 Date of RFT Remarks lxxvii

LF -02/A Register for Recording " other cases " Name of PHC- District- State- S. No. Age Sex Complete address to which the patient belongs (must record village/block/distt/state) Diagnosis (PB/MB) Relapse Partial treated old cases Rentered for treatment Type of case Referred cases Change in classification to PB/MB Patient belong to State/UT of lxxviii

LF-02/A Contd. Register for Recording " other cases " Treatment record with date Disablity status Gr.I/Gr.II 1 2 3 4 5 6 7 8 9 10 11 12 Date of RFT Remarks lxxix

3. Leprosy MDT Drug Stock Record The MDT Drug Stock Record (L.F. 03) is to be maintained in all PHC/Block PHC/CHC where MDT is supplied from the district and stocked. This is to be maintained in a Register. Separate pages should be used for each of the 4 types of MDT Blister Packs supplied viz. MB (Adult), MB (Child), PB (Adult), PB (Child). Guidelines to fill up the form Transaction Date Quantity received/issued Date on which the drug is received or issued (Expenditure). Number of Blister Calendar Packs (BCP) received or issued From where Source of receipt say DLO Ghaziabad or Block PHC Madhubani Vide Reference No. Batch No. Expiry Date To whom Balance in hand Remarks No. & date of order under which the drug has been supplied/ issued. As recorded in the BCP cover/ packing box As recorded in the BCP cover/ packing box Indicate to whom issued say Mornoi sub centre Enter quantity as should be available as per Record. (Must enter on each transaction date) Record any receipt in damaged condition, shortage in receipt against Ref. No., discoloration appearing at any time etc. giving quantity and indicating action taken. Similar form (L.F. 03) is to be used at District and State level drug stores also. Hospitals in urban situations and NGO Institutions should also keep similar records. Drug stock records are important document and should not be changed annually. Same Register can be used for number of years. The record will be retained in the Health centre/hospital/ngo Institute/District/State for future reference and audit. lxxx

Annexure III L.F. 03 NLEP LEPROSY MDT DRUG STOCK RECORD Use separate page for each category of MDT [MB(A)/ MB(C)/ PB(A)/ PB(C)] Specify category : (Same format to be used at PHC/District/State levels Please specify level with name along with next highest level up to State) PHC Block PHC/ CHC District State Fiscal Year Transaction Date Quantity. Received From Where Receipt Vide Ref. No. Batch No. Expiry Date Quantity Issued Vide Ref. No Expenditure To whom Batch No. Expiry date Balance In Hand Remarks lxxxi

4. Reports The data recorded in various centers need to be periodically collected and put in a pre designed format for sending to the next higher level for further use. These are called the reporting formats. The Simplified Information System under NLEP has accepted the following two reporting formats ML.F. 04 NLEP monthly reporting form PHC/Block PHC report 4.1 NLEP Monthly reporting form - PHC The ML.F. 04 form will be utilized by the Primary Health Centre, which is the basic recording unit under NLEP. This simple form will be filed up from the data available in the Treatment record and the Drug Stock record maintained at the PHC. 4.1.1 Guideline for filling the form Put name of PHC/Block PHC/District/State/reporting month and Fiscal year at the top. S.No. 1 No. of cases at the beginning of the reporting month i.e. S.No. 5 of previous month s report S.No. 2 Total New Leprosy cases detected in the reporting month (Adult & child) Put PB and MB cases in space provided in 1 st column and put total in white space provided in right hand column. S.No. 3 Among the new leprosy cases detected, number of Put specific number in the 1 st column provided. S.No. 4 Number of cases deleted in the reporting month RFT Number, released from treatment after completion of all doses of MDT. Others Deleted from record due to Death/ Migration/ absent for more than 3 months (PB) / six months (MB) / unknown reason. Put total in the blank space given in right hand column. S.No. 5 Number of cases at the end of the reporting month Put figure arrived at by adding total in S.No. 1 and S. No. 2 and then subtracting total in S.No. 4. S.No. 6 No: of other cases recorded and put under treatment. Relapse, re-entry, transferred in, referred, change in classification or migrated from other states. S.No. 7 Number of other cases deleted due to completion of treatment or due to other reasons like migration/ transfer out/ death etc. S. No. 8 Total number of other cases; PB, MB & Total; under treatment (6-7) S. No. 9 Leprosy drug stock at the end of the reporting month Put balance quantity of each drug a per record on the last date of transaction, Specify expiry date along with the quantity with that expiry date, calculate no; of BCPs available for each patient under treatment. Remarks: Any important information to be included regarding drug shortage. The report is to be signed by the Medical Officer In-charge of the PHC. The same form should be used by Hospitals/NGO Institutions also lxxxii

NLEP Monthly Reporting Form PHC / Block PHC Report M.L.F. 04/ A [ Page 1] PHC District Reporting Month Block State Year 1. No. of balance new cases at the beginning of the month PB TOTAL 2. No.of New Leprosy Cases detected in the reporting month During reporting month 3. Among new leprosy cases detected during the reporting month, number of Adult Child Total Female Deformity 4. Number of New leprosy cases deleted during the month RFT - Otherwise deleted 6. 5 Number of New leprosy cases under treatment at the end of the month (1+2-4) 7 8 Number of "other cases" recorded and put under treatment No. of 'other cases' deleted from treatment No. of other cases under treatment at the end of reporting month SC ST Total (i) Relapsed MB Grade-I Grade-II (ii) Reentered for treatment (iii) Referred (iv) Reclassified (v) From other states Total RFT Otherwise deleted Total PB MB TOTAL 9 Leprosy Drug Stock at the end of the reporting month (if required use extra sheets) : Blister Pack Quantity Expiry Date Total stock No. of patients under treatment Patient monthbcp MB (C) PB (C) lxxxiii

MLF 04/A [Page 2] S.NO. DPMR activities During reporting month PB MB Total 1 No. of reaction cases recorded 2 No.of reaction cases managed at PHC 3 No.of reaction cases referred to Dist. Hosp. /other instt. 4 No. of suspected relapse cases and referred by PHCs 5 No. of relapse confirmed at District Hospital 5 No. of cases developed new disability after MDT 6 No. of patients provided with footwear 7 No. of patients provided with self care kit 8 No. of patients referred for RCS at tertiary instt. 9 No. of instt, providing RCS 10 No. of cases referred for skin smear 11 No. found +ve for AFB Date : Name and Signature of the Medical Officer lxxxiv

Anaesthesia palm Claw hand Ulcer Absorption of finger Any other disability Anaesthesia sole Foot drop Ulcer Foot Absorption of toes Other disabilities (Foot) Lagophthalmos Low Vision Red Eye Disability Register PHC / primary care unit District State Form P I 1 S.No Name of the patient Age/ Sex Postal address Date of Registration Type of leprosy Treatment (MDT) status (No. of BCP taken) Column No. 1 2 3 4 5 6 7 8 Disability Grade 2 Hands Feet Eye Services provided with date Change / progress noticed Referred to with date Column No. 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Date Services Date Changes lxxxv

5.0 How to fill up the Form P-I Column 1: Serial no. to disabled cases is to be given Column 2: Complete name with surname along with son / daughter / wife of should be written Column 3: If patient is unable to tell the age, age should be assessed Column 4: Complete postal address with landmark / PIN to be given Column 5: Date of registration for MDT is to be written Column 6: PB or MB is to be written Column 7: Total number of BCP, MDT should be written Column 9 to 21: Tick mark on disability detected, more than 1 disability may be there. Column 22-23: Services such as self care training, ulcer care, surgery, issuing MCR shoes, refer to secondary level etc. may be entered along with respective dates. Column 24-25: Changes like ulcer healed, ulcer recurred, contractual developed, vision deteriorated new nerve damaged noticed etc. lxxxvi

Form P III Record of Lepra Reaction/ Neuritis (LRN) cases PHC/ district No.1 S. No. No.2 No.3 No.4 No.5 Name of the patient Date of MDT No. / registration Type of leprosy registration No. MB PB Type I No.6 Lepra Reaction Neuritis II Y N No.7 Treatment given Prednisolone doses issued with dates No.8 Other drugs No.9 New disability developed After start of prednisolone Yes No No.10 Remarks How to fill up the Form I Column 1: Serial no. of reaction cases is to be given Column 2: Complete name with surname along with son / daughter / wife of should be written Column 3: Date of registration of MDT is to be written Column 7: Doses of Prednisolone in milligram with date of issue to be filled Column 8: Enter Clofazimine, Analgesics, Mebandazole, or any other drug given. Column 9: In case of yes, write the nature and site(lt /RT) of disability developed lxxxvii

Form P II Disability Assessment form Assessment of Disability & Nerve Function Name Village Dt. of Regn S/o, W/o, D/o Sub Centre Dt. of RFT Gender/Age MDT No. Referred by Occupation MB/PB Date of assessment On date RIGHT Max. (WHO) Disability Grade EHF score Signature of Assessor Date Vision (0,1,2) Light Closure lid gap in mm. Blink Present / Absent Little Finger Out Thumb Up Wrist Extension Foot Up Disability Grade Hands Disability Grade Feet Disability Grade Eyes LEFT Muscle power: S = Strong W = Weak P = Paralysis Score of vision: counting fingers at 6 meters 0 = Normal 1= Blurring vision 2 = Unable to count fingers This form should be filled-in at the time of registration and repeated after 3 months (once in 2 weeks in case of neuritis/reaction) lxxxviii

SENSORY ASSESSMENT DATE / ASSESSOR Palm Sole Comments RIGHT LEFT RIGHT LEFT Key : (Put these mark/icon on the site where lesion is seen) Sensation Present within 3 cms Contracture Anaesthesia Wound Clawing Crack Scar/Callus Shortening Level lxxxix

Form P III Record of Lepra Reaction/ Neuritis (LRN) cases PHC/ district No.1 S. No. No.2 No.3 No.4 No.5 Name of the patient Date of MDT No. / registration Type of leprosy registration No. MB PB Type I No.6 Lepra Reaction Neuritis II Y N No.7 Treatment given Prednisolone doses issued with dates No.8 Other drugs No.9 New disability developed After start of prednisolone Yes No No.10 Remarks How to fill up the Form I Column 1: Serial no. of reaction cases is to be given Column 2: Complete name with surname along with son / daughter / wife of should be written Column 3: Date of registration of MDT is to be written Column 7: Doses of Prednisolone in milligram with date of issue to be filled Column 8: Enter Clofazimine, Analgesics, Mebendazole, or any other drug given. Column 9: In case of yes, write the nature and site (LT /RT) of disability developed xc

Form P IV Prednisolone Card (This card should be kept with the patient) INSTRUCTIONS TAKE PREDNISOLONE TABLETS AS SINGLE DOSE DAILY WITH MILK / FOOD BUT NEVER ON EMPTY STOMACH RESTRICT SALT INTAKE TILL ON PREDNISOLONE INFORM SOON IF YOU NOTICE BLACK STOOL (MALENA), PAIN UPPER ABDOMEN OR VOMITING NATIONAL LEPROSY ERADICATION PROGRAMME PREDNISOLONE CARD Name of the patient.. Reg. No./ MDT No. INFORM IMMEDIATELY IF DISCHARGE IN PLANTER ULCER, ANY FOCUS OF INFECTION, PERSISTING COUGH, MILD FEVER OR ANY DETERIORATION DON T STOP PREDNISOLONE BEFORE COMPLETION OF REGIMEN, EVEN IF THERE IS IMPROVEMENT OR DETERIORATION. REPORT FOR REVIEW / CHECKUP AND NEXT DOSAGE, EVERY FORTNIGHT Type MB / PB Date / Due Date of RFT. Indication for Prednisolone therapy: Date of starting Prednisolone... PREDNISOLONE RECORD Other drugs issued.. Dosage Date of issue Next due date Signature 40mg x 2 wk. 30mg x 2 wk. 20mg x 2 wk. Do (if required)... Progress / Remarks 15mg x 2 wk. 10mg x 2 wk. 5mg x 2 wk. Signature of MO.. Name. xci

Referral Register PHC district State S.No. Name of the person Age and Sex Address Reason / indication for referring Referred to Date of referral Referral services provided Follow-up actions taken with date Form P V Date action xcii

Form P VI Referral Slip (to be used by peripheral health worker) PHC District State Name of the person to be referred: Age and Sex : Address : Clinical finding : Reason / indication : for referring Referred to: Referred by (designation & place) : Signature & date : xciii

Referral Slip (to be used by MO PHC) Form P VII PHC District State Name of the person to be referred: Age and Sex : Address : Clinical finding : Reason / indication : for referring Referred to: Copy marked to District Nucleus on: Action taken at referral centers : instructions for follow up: Referred by (designation & place) : Signature & date : xciv

Anaesthesia palm Claw hand Ulcer Absorption of finger Any other disability Anaesthesia sole Foot drop Ulcer Foot Absorption of toes Other disabilities (Foot) Lagophthalmos Low Vision Red Eye Profile of disabled leprosy cases of PHC Form - P.VIII PHC District State Date of Report S.No. Total no. of leprosy cases on record No. of leprosy cases assessed for disability No. of cases with disability Gr I Gr II Total Column No. 1 2 3 4 5 6 7 8 9 10 No. of cases disability wise Hands Feet Eye Action (management) taken / to be taken Column No. 11 12 13 14 15 16 17 18 19 20 21 22 23 24 xcv